Abstract:Objectives: To evaluate the safety and efficacy of microwave ablation (MWA) for stage I non-small cell lung cancer (NSCLC) in patients with idiopathic pulmonary fibrosis (IPF). Materials and methods: A retrospective single-center cohort study was conducted in patients with clinical stage I NSCLC who underwent CT-guided MWA from Nov 2016 to Oct 2021. The patients were divided into the IPF group and the non-IPF group. The primary endpoints were 90-day adverse events and hospital length of stay (HLOS). The secondary endpoints included overall survival (OS) and progression-free survival (PFS). Results: A total of 107 patients (27 with IPF and 80 without IPF) were finally included for analysis. No procedure-related acute exacerbation of IPF or death occurred post-MWA. The rates of adverse events were similar between the groups (48.6% vs. 47.7%; p = 0.998). The incidence of grade 3 adverse events in the IPF group was higher than that in the non-IPF group without a significant difference (13.5% vs. 4.6%; p = 0.123). Median HLOS was 5 days in both groups without a significant difference (p = 0.078). The 1-year and 3-year OS were 85.2%/51.6% in the IPF group, and 97.5%/86.4% in the non-IPF group. The survival of patients with IPF was significantly poorer than the survival of patients without IPF (p < 0.001). There was no significant difference for PFS (p = 0.271). Conclusion: MWA was feasible in the treatment of stage I NSCLC in patients with IPF. IPF had an adverse effect on the survival of stage I NSCLC treated with MWA. Clinical relevance statement: CT-guided microwave ablation is a well-tolerated and effective potential alternative treatment for stage I non-small cell lung cancer in patients with idiopathic pulmonary fibrosis. Key points: • Microwave ablation for stage I non-small cell lung cancer was well-tolerated without procedure-related acute exacerbation of idiopathic pulmonary fibrosis and death in patients with idiopathic pulmonary fibrosis. • No differences were observed in the incidence of adverse events between patients with idiopathic pulmonary fibrosis and those without idiopathic pulmonary fibrosis after microwave ablation (48.6% vs. 47.7%; p = 0.998). • The 1-year and 3-year overall survival rates (85.2%/51.6%) in the idiopathic pulmonary fibrosis group were worse than those in the non- idiopathic pulmonary fibrosis group (97.5%/86.4%) (p < 0.001).

Invasive Pulmonary Aspergillosis Secondary to Microwave Ablation: a Multicenter Retrospective Study.

Invasive Pulmonary Aspergillosis: A Rare Complication After Microwave Ablation

Major Complications After Lung Microwave Ablation: A Single-Center Experience on 204 Sessions

Invasive pulmonary aspergillosis in patients with acute-on-chronic liver failure.

Risk Factors for Invasive Pulmonary Aspergillosis and Hospital Mortality in Acute-On-Chronic Liver Failure Patients: A Retrospective-Cohort Study

Safety and efficacy of CT-guided percutaneous microwave ablation for stage I non-small cell lung cancer in patients with comorbid idiopathic pulmonary fibrosis

Liver Abscess As a Complication of Microwave Ablation for Liver Metastatic Cholangiocarcinoma after Bilioenteric Anastomosis.

Clinical and Survival Outcomes of Percutaneous Microwave Ablation for Intrahepatic Cholangiocarcinoma

Clinical characteristics of 45 patients with invasive pulmonary aspergillosis: retrospective analysis of 1711 lung cancer cases.

CT-guided Percutaneous Microwave Ablation of Pulmonary Malignancies: Results in 69 Cases

Microwave Ablation for Malignant Central Airway Obstruction: A Pilot Study

[Complications and Clinical Outcomes of Microwave Ablation for Liver Metastatic Cholangiocarcinoma after Bilioenteric Anastomosis].

Invasive Pulmonary Aspergillosis in Patients with Antineutrophil Cytoplasmic Antibody Associated Vasculitis.

Malignant liver tumors: treatment with percutaneous microwave ablation--complications among cohort of 1136 patients.

A Case of Pulmonary MALToma Camouflaged Within Invasive Pulmonary Aspergillosis

Microwave Ablation after VATS in Patients with Multiple Pulmonary Nodules

Subacute invasive pulmonary aspergillosis after chemoradiotherapy for lung cancer

The Safety And Efficacy Of Microwave Ablation For The Treatment Of Crc Pulmonary Metastases

Microwave Ablation in Combination with Chemotherapy for the Treatment of Advanced Non-Small Cell Lung Cancer

Computed tomography-guided percutaneous microwave ablation for treatment of peripheral ground-glass opacity–Lung adenocarcinoma: A pilot study

Changes in the Pulmonary Function of CT-guided Microwave Ablation for Patients with Malignant Lung Tumors.